(Q46806933)

25 December 2017

title

Aspirin resistance and diabetes mellitus (English)

1 reference

25 December 2017

1 reference

2

1 reference

25 December 2017

author name string

R Ajjan

series ordinal

1

1 reference

25 December 2017

P J Grant

series ordinal

3

1 reference

25 December 2017

publication date

1 March 2008

1 reference

25 December 2017

published in

Diabetologia

1 reference

25 December 2017

volume

51

1 reference

25 December 2017

issue

3

1 reference

25 December 2017

page(s)

385-390

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1007/s00125-007-0898-3

exact match

0 references

cites work

Narrative review: aspirin resistance and its clinical implications

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-007-0898-3

Clinical pharmacology of platelet cyclooxygenase inhibition

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-007-0898-3

Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-007-0898-3

Comparison of aspirin resistance in type 1 versus type 2 diabetes mellitus

21 January 2018

1 reference

12 December 2020

Prevalence of aspirin resistance in patients with type 2 diabetes

1 reference

12 December 2020

Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy

1 reference

12 December 2020

In vitro Acetylation of Plasma Proteins, Enzymes and DNA by Aspirin

1 reference

12 December 2020

Biological effects of aspirin and clopidogrel in a randomized cross-over study in 96 healthy volunteers

1 reference

12 December 2020

Coagulation and atherothrombotic disease

1 reference

12 December 2020

Better increase in fibrin gel porosity by low dose than intermediate dose acetylsalicylic acid

1 reference

12 December 2020

The collagen-platelet interaction

1 reference

12 December 2020

Acetylation of the NH2-terminal serine of prostaglandin synthetase by aspirin

1 reference

12 December 2020

Review article: gastrointestinal bleeding with low-dose aspirin - what's the risk?

1 reference

12 December 2020

Increased basal platelet activity, plasma adiponectin levels, and diabetes mellitus are associated with poor platelet responsiveness to in vitro effect of aspirin

1 reference

12 December 2020

Profile and prevalence of aspirin resistance in patients with cardiovascular disease

1 reference

12 December 2020

Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin

1 reference

12 December 2020

Biology and pharmacology of the platelet P2Y12 receptor

1 reference

12 December 2020

Aspirin resistance and atherothrombotic disease

1 reference

12 December 2020

Trial of repeated low-dose aspirin in diabetic angiopathy

1 reference

12 December 2020

Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease

1 reference

12 December 2020

Marked increase of fibrin gel permeability with very low dose ASA treatment

1 reference

12 December 2020

Prevention of cardiovascular disease in type-2 diabetes: how to improve the clinical efficacy of aspirin

1 reference

12 December 2020

Platelet aggregation and thromboxane release induced by arachidonic acid, collagen, ADP and platelet-activating factor following low dose acetylsalicylic acid in man

1 reference

12 December 2020

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

12 December 2020

Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14. ETDRS Investigators

1 reference

12 December 2020

Measurement of thrombin generation in whole blood--the effect of heparin and aspirin

1 reference

12 December 2020

Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus

1 reference

12 December 2020

Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients

1 reference

12 December 2020

Dependence of human platelet functional responses on divalent cations: aggregation and secretion in heparin- and hirudin-anticoagulated platelet-rich plasma and the effects of chelating agents

1 reference

12 December 2020

Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus

1 reference

12 December 2020

Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial

1 reference

12 December 2020

Acetyl- L -carnitine decreases glycation of lens proteins: in vitro studies

1 reference

12 December 2020

Aspirin alters the cardioprotective effects of the factor XIII Val34Leu polymorphism

1 reference

12 December 2020

Phospholipase A2: function and pharmacological regulation

1 reference

12 December 2020

Temporal trends in mortality of patients with diabetes mellitus suffering acute myocardial infarction: a comparison of over 3000 patients between 1995 and 2003

1 reference

12 December 2020

Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin)-its relation to metabolic control

1 reference

12 December 2020

Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age

1 reference

12 December 2020

Inhibition of glycation of albumin and hemoglobin by acetylation in vitro and in vivo

1 reference

12 December 2020

Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction

1 reference

12 December 2020

High glucose contributes to aspirin insensitivity in streptozotocin-diabetic rats: a multiparametric aggregation study

1 reference

12 December 2020

Blood platelet abnormalities and pharmacological modulation of platelet reactivity in patients with diabetes mellitus

1 reference

12 December 2020

Modified clotting properties of fibrinogen in the presence of acetylsalicylic acid in a purified system

1 reference

12 December 2020

AHA/ADA vs. ESC/EASD recommendations on aspirin as a primary prevention strategy in people with diabetes: how the same data generate divergent conclusions

1 reference

12 December 2020

10.1007/S00125-007-0898-3

Identifiers

DOI

1 reference

25 December 2017

PubMed ID

18197397

1 reference

25 December 2017